Eisai
4523.T
#2132
Rank
โ‚น856.37 B
Marketcap
โ‚น3,034
Share price
1.57%
Change (1 day)
15.39%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น82.25. In 2026 the company made an earnings per share (EPS) of โ‚น81.89 a decrease over its 2025 EPS that were of โ‚น103.71.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026โ‚น81.89-21.04%
2025โ‚น103.7111.85%
2024โ‚น92.72-32.63%
2023โ‚น137.635.52%
2022โ‚น130.43-74.01%
2021โ‚น501.80-66.58%
2020โ‚น1,50198.24%
2019โ‚น757.3017.01%
2018โ‚น647.2037.78%
2017โ‚น469.75-27.62%
2016โ‚น649.0235.33%
2015โ‚น479.58-2.82%
2014โ‚น493.51-27.66%
2013โ‚น682.25-27.49%
2012โ‚น940.95-12.67%
2011โ‚น1,07888.08%
2010โ‚น572.90-11.06%
2009โ‚น644.16-390.15%
2008-โ‚น222.01-127.78%
2007โ‚น799.28347.11%
2006โ‚น178.774.38%
2005โ‚น171.277.4%
2004โ‚น159.4843.03%
2003โ‚น111.5025.09%
2002โ‚น89.1452.67%
2001โ‚น58.3869.76%
2000โ‚น34.39